TP53 and cancer: Many clinical reports have shown that the combination of p53 gene therapy with chemotherapy or radiotherapy can effectively control disease progression, improve progression-free survival time in cancer patients, and lead to better outcomes than gene therapy or radiotherapy [62,63].